TABLE 2. Second-dose completion status and interval between first and second dose among persons who initiated the COVID-19 vaccination series, by jurisdiction and demographic characteristics — United States, December 14, 2020–February 14, 2021*.
| Jurisdiction and demographic characteristic | Completion status† among persons with sufficient time to receive second dose (%) |
Dosing interval among persons who received second dose (%) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| No. | Completed series | No second dose but remained within allowable interval§ | Missed second dose¶ | No. | Early** | During recommended interval†† | After recommended interval but within allowable interval§§ | Late¶¶ | |
|
Total, no. (%)
|
12,496,258
|
10,999,097 (88.0)
|
1,078,336 (8.6)
|
418,825 (3.4)
|
14,205,768
|
216,905 (1.5)
|
13,582,544 (95.6)
|
392,935 (2.8)
|
13,384 (0.1)
|
|
State/Area
| |||||||||
| Alabama |
129,629
|
(87.3) |
(9.9) |
(2.8) |
150,202
|
(2.1) |
(95.7) |
(2.1) |
(0.1) |
| Alaska |
57,293
|
(90.5) |
(6.9) |
(2.6) |
68,344
|
(0.9) |
(97.9) |
(1.2) |
(0.0) |
| Arizona |
274,548
|
(85.4) |
(11.6) |
(2.9) |
300,844
|
(3.2) |
(90.8) |
(5.9) |
(0.1) |
| Arkansas |
147,459
|
(82.8) |
(12.4) |
(4.7) |
148,477
|
(1.4) |
(96.6) |
(2.0) |
(0.1) |
| California |
1,269,213
|
(87.2) |
(9.0) |
(3.8) |
1,538,150
|
(1.2) |
(96.4) |
(2.3) |
(0.1) |
| Colorado |
280,523
|
(94.2) |
(4.1) |
(1.7) |
328,338
|
(0.9) |
(97.4) |
(1.6) |
(0.1) |
| Connecticut |
234,761
|
(82.9) |
(14.5) |
(2.6) |
256,784
|
(7.5) |
(86.4) |
(5.3) |
(0.8) |
| Delaware |
35,454
|
(87.6) |
(9.9) |
(2.5) |
37,387
|
(1.0) |
(92.1) |
(6.8) |
(0.1) |
| District of Columbia |
45,206
|
(85.6) |
(10.4) |
(4.0) |
46,137
|
(1.3) |
(96.4) |
(2.2) |
(0.0) |
| Florida |
1,094,586
|
(87.8) |
(9.1) |
(3.1) |
1,218,397
|
(2.0) |
(95.4) |
(2.6) |
(0.1) |
| Georgia |
362,414
|
(88.9) |
(8.4) |
(2.7) |
443,669
|
(1.8) |
(94.9) |
(3.2) |
(0.1) |
| Hawaii |
19,023
|
(88.9) |
(6.8) |
(4.3) |
20,147
|
(0.8) |
(93.3) |
(5.8) |
(0.1) |
| Idaho |
54,880
|
(93.1) |
(4.9) |
(2.0) |
70,856
|
(1.4) |
(97.2) |
(1.3) |
(0.1) |
| Illinois |
419,419
|
(85.5) |
(9.4) |
(5.0) |
449,475
|
(1.1) |
(97.2) |
(1.7) |
(0.1) |
| Indiana |
275,381
|
(90.3) |
(8.7) |
(1.0) |
312,681
|
(1.0) |
(96.8) |
(2.1) |
(0.1) |
| Iowa |
138,418
|
(81.8) |
(16.2) |
(2.0) |
129,403
|
(0.5) |
(93.5) |
(5.8) |
(0.2) |
| Kansas |
116,535
|
(87.0) |
(7.6) |
(5.4) |
122,686
|
(2.0) |
(94.6) |
(3.4) |
(0.1) |
| Kentucky |
199,398
|
(84.0) |
(10.2) |
(5.8) |
210,892
|
(0.6) |
(96.1) |
(3.3) |
(0.1) |
| Louisiana |
234,624
|
(94.4) |
(4.7) |
(0.9) |
274,481
|
(0.9) |
(98.3) |
(0.8) |
(0.0) |
| Maine |
62,633
|
(89.2) |
(5.8) |
(4.9) |
68,479
|
(0.3) |
(98.2) |
(1.3) |
(0.1) |
| Maryland |
231,172
|
(91.4) |
(6.9) |
(1.7) |
266,356
|
(0.8) |
(94.2) |
(4.9) |
(0.1) |
| Massachusetts |
294,106
|
(82.1) |
(11.4) |
(6.6) |
305,083
|
(1.3) |
(96.6) |
(2.0) |
(0.1) |
| Michigan |
447,555
|
(95.4) |
(3.4) |
(1.2) |
538,614
|
(0.6) |
(97.3) |
(2.1) |
(0.1) |
| Minnesota |
217,567
|
(90.5) |
(6.3) |
(3.2) |
255,434
|
(2.1) |
(95.4) |
(2.5) |
(0.0) |
| Mississippi |
103,965
|
(89.8) |
(8.8) |
(1.3) |
128,671
|
(1.1) |
(95.9) |
(3.0) |
(0.1) |
| Missouri |
216,227
|
(93.0) |
(4.5) |
(2.5) |
265,192
|
(0.6) |
(96.9) |
(2.4) |
(0.1) |
| Montana |
50,572
|
(90.9) |
(5.4) |
(3.6) |
57,032
|
(1.4) |
(95.4) |
(3.1) |
(0.2) |
| Nebraska |
94,464
|
(90.3) |
(5.4) |
(4.3) |
102,101
|
(0.7) |
(96.5) |
(2.7) |
(0.1) |
| Nevada |
95,396
|
(91.7) |
(5.7) |
(2.6) |
125,342
|
(1.0) |
(96.7) |
(2.2) |
(0.1) |
| New Hampshire |
84,323
|
(93.5) |
(4.2) |
(2.3) |
95,776
|
(8.7) |
(82.3) |
(8.3) |
(0.7) |
| New Jersey |
324,161
|
(87.7) |
(9.1) |
(3.1) |
388,744
|
(0.6) |
(97.5) |
(1.9) |
(0.0) |
| New Mexico |
142,008
|
(87.4) |
(8.5) |
(4.1) |
163,459
|
(1.4) |
(96.0) |
(2.5) |
(0.1) |
| New York |
823,922
|
(87.2) |
(8.6) |
(4.2) |
968,811
|
(1.0) |
(96.9) |
(2.1) |
(0.1) |
| North Carolina |
419,220
|
(91.0) |
(5.7) |
(3.3) |
534,863
|
(0.7) |
(96.4) |
(2.8) |
(0.1) |
| North Dakota |
47,682
|
(93.3) |
(4.2) |
(2.5) |
53,008
|
(3.1) |
(94.1) |
(2.7) |
(0.1) |
| Ohio |
436,574
|
(89.6) |
(7.7) |
(2.7) |
515,733
|
(1.4) |
(95.0) |
(3.5) |
(0.1) |
| Oklahoma |
231,600
|
(87.7) |
(9.6) |
(2.7) |
240,072
|
(0.6) |
(96.8) |
(2.6) |
(0.1) |
| Oregon |
189,028
|
(92.9) |
(5.5) |
(1.6) |
213,812
|
(0.6) |
(96.7) |
(2.6) |
(0.1) |
| Pennsylvania |
479,037
|
(87.6) |
(9.2) |
(3.2) |
522,255
|
(1.6) |
(96.0) |
(2.4) |
(0.1) |
| Rhode Island |
47,308
|
(93.8) |
(4.3) |
(2.0) |
53,769
|
(0.8) |
(95.9) |
(3.2) |
(0.1) |
| South Carolina |
181,871
|
(80.6) |
(16.9) |
(2.5) |
197,410
|
(3.2) |
(94.5) |
(2.3) |
(0.0) |
| South Dakota |
58,551
|
(89.7) |
(6.7) |
(3.5) |
62,266
|
(0.3) |
(96.6) |
(3.0) |
(0.1) |
| Tennessee |
311,579
|
(91.9) |
(4.9) |
(3.2) |
329,446
|
(1.6) |
(95.5) |
(2.8) |
(0.1) |
| Utah |
147,885
|
(75.3) |
(20.7) |
(4.0) |
126,507
|
(2.1) |
(90.5) |
(7.2) |
(0.1) |
| Vermont |
36,563
|
(91.9) |
(5.3) |
(2.8) |
38,759
|
(1.2) |
(97.6) |
(1.2) |
(0.0) |
| Virginia |
345,645
|
(82.6) |
(9.6) |
(7.8) |
386,384
|
(0.8) |
(96.3) |
(2.8) |
(0.1) |
| Washington |
285,288
|
(87.5) |
(9.4) |
(3.2) |
321,080
|
(1.7) |
(95.4) |
(2.8) |
(0.1) |
| West Virginia |
167,867
|
(95.8) |
(2.5) |
(1.7) |
201,504
|
(6.6) |
(85.5) |
(7.4) |
(0.4) |
| Wisconsin |
216,685
|
(93.5) |
(5.2) |
(1.3) |
260,163
|
(0.6) |
(96.5) |
(2.9) |
(0.0) |
| Wyoming |
27,746
|
(88.2) |
(9.5) |
(2.3) |
31,486
|
(1.4) |
(95.8) |
(2.8) |
(0.1) |
|
Territories and freely associated states
| |||||||||
| American Samoa |
3,509
|
(95.9) |
(2.9) |
(1.3) |
6,047
|
(0.2) |
(99.4) |
(0.4) |
(0.0) |
| Federated States of Micronesia |
577
|
(85.1) |
(14.9) |
(0.0) |
895
|
(1.0) |
(79.0) |
(20.0) |
(0.0) |
| Guam |
10,447
|
(87.0) |
(8.3) |
(4.7) |
12,557
|
(0.5) |
(98.9) |
(0.6) |
(0.0) |
| Marshall Islands |
707
|
(76.8) |
(14.1) |
(9.1) |
725
|
(0.4) |
(98.3) |
(1.2) |
(0.0) |
| Northern Mariana Islands |
4,408
|
(98.7) |
(0.6) |
(0.7) |
5,266
|
(0.1) |
(99.7) |
(0.2) |
(0.1) |
| Palau |
726
|
(99.7) |
(0.3) |
(0.0) |
1,566
|
(0.1) |
(99.9) |
(0.1) |
(0.0) |
| Puerto Rico |
138,612
|
(79.0) |
(15.1) |
(5.9) |
128,887
|
(1.0) |
(98.5) |
(0.5) |
(0.0) |
| U.S. Virgin Islands |
4,107
|
(85.1) |
(9.2) |
(5.6) |
4,211
|
(1.9) |
(94.8) |
(3.1) |
(0.1) |
|
Demographic characteristics
| |||||||||
| Race/Ethnicity*** |
6,764,604
|
— |
— |
— |
8,002,280
|
— |
— |
— |
— |
| AI/AN, non-Hispanic |
145,449
|
(83.7) |
(11.2) |
(5.1) |
148,823
|
(1.5) |
(96.0) |
(2.4) |
(0.1) |
| Asian, non-Hispanic |
365,379
|
(90.2) |
(7.0) |
(2.8) |
428,595
|
(1.2) |
(95.9) |
(2.8) |
(0.1) |
| Black, non-Hispanic |
366,442
|
(88.8) |
(8.6) |
(2.6) |
436,647
|
(1.8) |
(95.1) |
(3.1) |
(0.1) |
| Hispanic |
718,384
|
(87.0) |
(9.5) |
(3.5) |
812,235
|
(1.4) |
(95.8) |
(2.8) |
(0.1) |
| Multiple/Other, non-Hispanic |
1,013,031
|
(86.1) |
(10.7) |
(3.2) |
1,152,231
|
(1.4) |
(96.5) |
(2.0) |
(0.1) |
| NHPI, non-Hispanic |
17,755
|
(90.3) |
(6.8) |
(2.9) |
20,042
|
(1.0) |
(96.1) |
(2.7) |
(0.1) |
| White, non-Hispanic |
4,138,164
|
(90.3) |
(7.4) |
(2.3) |
5,003,707
|
(1.7) |
(95.0) |
(3.1) |
(0.1) |
| Age group, yrs |
12,489,174
|
— |
— |
— |
14,202,212
|
— |
— |
— |
— |
| 16–44 |
4,507,276
|
(88.1) |
(7.9) |
(4.0) |
4,653,564
|
(1.3) |
(95.0) |
(3.6) |
(0.1) |
| 45–64 |
4,211,791
|
(88.7) |
(7.7) |
(3.6) |
4,453,503
|
(1.4) |
(95.5) |
(3.0) |
(0.1) |
| ≥65 |
3,770,107
|
(87.2) |
(10.5) |
(2.3) |
5,095,145
|
(1.9) |
(96.3) |
(1.8) |
(0.0) |
| Sex |
12,128,929
|
— |
— |
— |
13,866,864
|
— |
— |
— |
— |
| Female |
7,675,229
|
(88.4) |
(8.4) |
(3.2) |
8,630,313
|
(1.5) |
(95.6) |
(2.8) |
(0.1) |
| Male | 4,453,700 | (87.8) | (8.9) | (3.2) | 5,236,551 | (1.6) | (95.6) | (2.7) | (0.1) |
Abbreviations: AI/AN = American Indian/Alaska Native; NHPI = Native Hawaiian or other Pacific Islander.
* Vaccines administered during December 14, 2020–February 14, 2021, and reported to CDC by February 20, 2021.
† Among persons who received their first dose on or before January 19 for Pfizer-BioNTech (>25 days between the first dose and February 14) or January 12 for Moderna (>32 days between the first dose and February 14).
§ 26–42 days (Pfizer-BioNTech) or 33–42 days (Moderna) after first dose; no second dose received.
¶ >42 days after first dose; no second dose received.
** Received second dose <17 days (Pfizer-BioNTech) or <24 days (Moderna) after first dose.
†† Received second dose 17–25 days (Pfizer-BioNTech) or 24–32 days (Moderna) after first dose.
§§ Received second dose 26–42 days (Pfizer-BioNTech) or 33–42 days (Moderna) after first dose.
¶¶ Received second dose >42 days after first dose.
*** Percentages were calculated among persons with available demographic characteristics.